Synapse - Elsevier Science Ltd.

Results (78)

Fludarabine-exposure predicts disease control following CD19-specific CAR T cell (tisagenlecleucel); A report from pediatric real-world CAR Consortium

Meeting Abstract

Curran, K. J.; Fabrizio, V. A.; Mauguen, A.; Boelens, J. J.; Baggott, C.; Prabhu, S.; Placenta, H.; Phillips, C. L.; Rossoff, J.; Stefanski, H.; more...
Cytotherapy (2021)

Fulltext@MSK | Save

Emerging trends in COVID-19 treatment: Learning from inflammatory conditions associated with cellular therapies

Review

Cancio, M.; Ciccocioppo, R.; Rocco, P. R. M.; Levine, B. L.; Bronte, V.; Bollard, C. M.; Weiss, D.; Boelens, J. J.; Hanley, P. J.
Cytotherapy (2020)

Fulltext@MSK | Save

Early CD4+ T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantation

Journal Article

van Roessel, I.; Prockop, S.; Klein, E.; Boulad, F.; Scaradavou, A.; Spitzer, B.; Kung, A.; Curran, K.; O'Reilly, R. J.; Kernan, N. A.; more...
Cytotherapy (2020)

Fulltext@MSK | Save

Treatment with banked 3rd party donor derived virus specific T cells: The advantages of pre-defined HLA restriction and epitope specificity

Meeting Abstract

Prockop, S.; Doubrovina, E.; Hasan, A.; O'Reilly, R. J.
Cytotherapy (2020)

Fulltext@MSK | Save

Epstein-Barr virus-specific cytotoxic T lymphocyte precursors (EBV-CTLp) after tabelecleucel correlates with response & survival in rituximab relapsing or refractory EBV posttransplant lymphoproliferative disease (PTLD)

Meeting Abstract

Prockop, S.; Shen, R. R.; Guzman-Becerra, N.; Sun, Y.; Forozan, F.; Doubrovina, E.; O'Reilly, R. J.; Li, X.; Hiremath, M.; Gamelin, L.; more...
Cytotherapy (2020)

Fulltext@MSK | Save

Establishing cGMP manufacturing of CRISPR/Cas9-edited human CAR T cells

Meeting Abstract

Wang, X.; Zabierowski, S.; Wu, M.; Del Casale, C.; Eyquem, J.; Mansilla-Soto, J.; Riviere, I.; Sadelain, M.
Cytotherapy (2020)

Fulltext@MSK | Save

Photography

Book Section

Serafin, J.; Dollinger, S. J. Encyclopedia of Creativity. 3rd ed (2019)

Fulltext@MSK | Save

Durable responses to 3rd party viral specific T cells mediated by different patterns of engraftment

Meeting Abstract

Prockop, S.; Doubrovina, E.; Hasan, A.; Suser, S.; Rodriguez-Sanchez, I.; Price, K.; Slocum, A.; O'Reilly, R. J.
Cytotherapy (2019)

Fulltext@MSK | Save

In T-cell lines dually sensitized with antigens from EBV and CMV or from EBV and WT1 the T-cells specific for CMV or WT1 are often restricted by HLA alleles that differ from those restricting T-cells specific for EBV